Navigation Links
ProGaming Platforms Corp. Executes Share Swap Agreement With BioMedix Ltd.
Date:2/18/2013

NEW YORK, February 18, 2013 /PRNewswire/ --

ProGaming Platforms Corp. ( OTCQB: PPTF), an Israeli-based developer of a commercial multiplayer online gaming and reward processing platform, today announced that it has entered into a share swap agreement with BioMedix Ltd., a publicly traded company on the Tel Aviv Stock Exchange (TASE). BioMedix, a leading Medical Device/Technology incubator, has agreed to purchase 1,229,055 restricted PPTF shares at a valuation of $.16 per PPTF share, via share swap of its publicly traded Israeli subsidiary, Gefen Biomed Investments Ltd. (GEFEN: TASE). In connection with this share swap transaction; PPTF received 921,790 shares of Gefen, which values the PPTF shares at $.16

The transaction with BioMedix was disclosed at the IL Maya system (Israeli SEC website) and can be viewed (in Hebrew) at:

http://maya.tase.co.il/bursa/report.asp?report_cd=790991-00&CompCd=368&Type=Pdf

Erez Zino , ProGaming's CEO, stated "ProGaming continues to progress in its efforts to bring added value to our shareholders. The funding that we receive upon from our sale of our Gefen shares will be used to enhance our ability to add personnel and acquire resources to augment our existing technology as well as to fund additional joint venture projects with strategic partners. We plan during the forthcoming weeks to continue to update our shareholders and the investment community with regard to our acquisition program."

Mr. Zino further stated that "ProGaming is continuing its efforts to improve cash flow, which will also improve our financial condition and should result in share price appreciation. Our long-term plan includes seeking to upgrade our share listings to higher level exchanges including foreign listings in the future."

About ProGaming Platforms Corp: ProGaming Platforms has developed what it believes is the ultimate gaming platform for the Internet's ultimate games. The platform automatically and accurately determines game winners from an unlimited pool of players and automatically pays monetary reward payouts. The platform can be integrated into any existing billing system, can be licensed by any online gaming provider and can sit on any third-party server. In addition, Progaming has developed a proprietary "state-of-the-art" multiplayer puzzle game which is integrated with its unique GER technology to match the Social media gaming needs.  

Learn more about ProGaming Platforms Corp. at http://www.progamingcorp.com. And http://www.progamingcorp.info for our products demonstration

About Biomedix and Gefen: Biomedix and its subsidiary, Gefen, are Israel-based, publicly-traded companies listed on TASE.  Biomedix is an investment management company focused primarily on Israeli-based Medical Device and Technology companies, from early stage to later stage/mature companies presenting high growth potential. Biomedix controls two of Israel's largest incubators, ATI and Meytav, as well as a late-stage investment entity, SpearHead. Gefen's risk management leverages its investment funds through the Israeli incubator program under the direction of the Office of the Israel Chief Scientist.

More information on BioMedix and Gefen can be found at: http://www.biomedixincubator.com and

http://www.gefenbiomed.com/, respectively

Forward-Looking Statements:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of ProGaming Platforms Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. ProGaming Platforms Corp. public filings may be viewed at http://www.sec.gov.

Contact:
Erez Zino , CEO
info@progamingcorp.com
+1-917-522-8377


'/>"/>
SOURCE ProGaming Platforms Corp
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InformEx Platforms Top Chemical Suppliers In The Specialty, Industrial & Pharmaceutical Ingredients Markets
2. Advanced Radiology Services (ARS) Selects IDS to Unify and Expand Its Clinical Documentation Platforms
3. Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
4. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
5. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
6. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
7. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
8. United BioSource Corp. erweitert mit entscheidender Neubesetzung Potenzial in Europa
9. United BioSource Corp. expande sus capacidades europeas con contrataciones clave
10. Home Access Health Corp. encourages cholesterol testing during American Heart Month, beyond
11. Free Research Report on Laboratory Corp. of America Holdings, Sony Corp., Cyberonics, Inc., Olin Corp. and Deluxe Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):